IR-Med raises $715K in private placement, appoints director, increases authorized shares to 600M

IR-Med, Inc.

Sold 715,000 common shares at $1.00 each and warrants to buy up to 1,144,000 shares at $1.00; gross proceeds $715,000.
Warrants exercisable from 6-month anniversary, 5-year term; one-time dilution protection if later offering at lower price.
Avital Rosenberg appointed Class I director and Audit Committee member; annual fee $5,000 plus $1,000 in-person / $300 virtual meeting fees.
Authorized common shares increased from 250M to 600M via amendment filed June 6, approved by shareholders on November 7, 2023.

item 1.01 item 3.02 item 5.02 item 5.03 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Avital Rosenberg

Class I Director

IR-Med, Inc.

Effective: 2024-06-04
Filed: June 10, 2024, 7:59 PM ET

On June 4, 2024, the board of directors (the “Board”) of the Company, appointed Ms. Avital Rosenberg to serve as a Class I director and a member of the Board’s Audit Committee, to fill an existing vacancy on the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Avital Rosenberg was appointed as Class I Director at IR-Med, Inc..

Action: appointed
Role: Class I Director

Exact text from the filing

On June 4, 2024, the board of directors (the “Board”) of the Company, appointed Ms. Avital Rosenberg to serve as a Class I director and a member of the Board’s Audit Committee, to fill an existing vacancy on the Board, effective immediately.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-023335

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.